THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: July 20, 2006 06:28 AM Thursday; Rod Welch

Millie asks doctor for strategy treating IBC 3rd relapse.

1...Summary/Objective
2...Strategy Treating IBC on 3rd Relapse Post-surgery Mastectomy
3...Chemotherapy Drugs and Combinations Available Systemic Treatment IBC
4...Radiation Treatment Tumor Board Review Develop Strategy IBC Relapse
5...Tumor Board Review Develop Strategy IBC Relapse Treatment Radiation
6...Nupigen Prescribe with Capecitiabine Taxotere Following Prior Guidance


..............
Click here to comment!

CONTACTS 

SUBJECTS
Strategy Treatment 3rd-Relapse IBC Letter Asks Primary Care Physicia

0503 -
0503 -    ..
0504 - Summary/Objective
0505 -
050501 - Follow up ref SDS 3 0000.
050502 -
050503 - Millie requested comments from primary care physician on strategy
050504 - treating 3rd relapse of IBC.
050505 -
050506 -         [On 060721 primary care physician responds. ref SDS 4 21A6
050507 -
050508 -
050510 -  ..
0506 -
0507 -
0508 - Progress
0509 -
050901 - Strategy Treating IBC on 3rd Relapse Post-surgery Mastectomy
050902 -
050903 - Follow up ref SDS 3 K36G, ref SDS 1 Q05H.
050904 -
050905 - Millie submitted ref DIT 1 0001 to the primary care physician that
050906 - follows up discussions during the meeting at Kaiser on 060711.
050907 -
050908 -    1.  Since we are on the 3rd relapse, ref DIT 1 0001, can you look
050909 -        through our meeting on July 11th -- just the part about
050910 -        treatment. ref SDS 3 K36G
050912 -  ..
050913 - This letter follows up discussions on developing a new work plan at
050914 - Kaiser on 060711. ref SDS 3 K36G
050915 -
050916 -
050917 -
050918 -
050919 -
050920 -
0510 -

SUBJECTS
Chemotherapy Drugs Combinations Available Systemic Treatment IBC Sou

0803 -
080401 -  ..
080402 - Chemotherapy Drugs and Combinations Available Systemic Treatment IBC
080403 -
080404 - Follow up ref SDS 3 PF3O.
080406 -  ..
080407 - Millie's letter to Kaiser continued...
080408 -
080409 -    2.  Key questions on treatment, ref SDS 3 KY4G, decisions are
080410 -        highlighted. ref DIT 1 GT6G
080411 -
080412 -    3.  If you don't have time to address this, is there a department
080413 -        at Kaiser that does anlaysis, ref DIT 1 GT6K, to develop
080414 -        strategy tied to patient history? ref SDS 3 OV9J
080416 -  ..
080417 - The record of the meeting on 060711 asks for the source of drugs used
080418 - for chemotherapy treatment. ref SDS 3 QO7O
080419 -
080420 -            [On 060721 primary care physician responded saying in part
080421 -            "What has or has not been done, what has or has not been
080422 -            effective, what we can or cannot do again in the future,"
080423 -            ref SDS 4 YU46; and continued saying "Currently our options
080424 -            are limited to a decreasing pool of chemotherapeutic
080425 -            agents." ref SDS 4 H45G
080427 -             ..
080428 -            [On 060806 letter notifies Kaiser that disease progressing
080429 -            rapidly, requires change in treatment plan. ref SDS 6 OJ7S
080430 -
080431 -
080432 -
080433 -
080434 -
080435 -
080436 -
0805 -

SUBJECTS
Treatment Options Tumor Board Review Strategy Treatment Plan Chemoth

2703 -
270401 -  ..
270402 - Radiation Treatment Tumor Board Review Develop Strategy IBC Relapse
270403 - Tumor Board Review Develop Strategy IBC Relapse Treatment Radiation
270404 -
270405 - Millie's letter to Kaiser continued...
270407 -         ..
270408 -    4.  Would the Tumor Board, ref SDS 3 Z26K, be of any help?
270409 -        ref DIT 1 TV7G
270411 -  ..
270412 - Background considering radiation treatment is reported in the record
270413 - on 060711, ref SDS 3 FP9H, and earlier on 060623, ref SDS 2 K36G,
270414 -
270415 -            [On 060721 primary care physician responded saying in part
270416 -            "Tumor Board could offer no more." ref SDS 4 IP9L
270417 -
270418 -
270419 -
270420 -
270421 -
270422 -
2705 -

SUBJECTS
Nupigen Prescribe with Capecitiabine Taxotere Following Prior Guidan

3003 -
300401 -  ..
300402 - Nupigen Prescribe with Capecitiabine Taxotere Following Prior Guidance
300403 -
300404 - Millie's letter to Kaiser continued...
300405 -
300406 -    5.  I also notice that nupigen was prescribed initially when we
300407 -        started Xeloda and Taxotere. ref SDS 3 O16H  This was left
300408 -        undecided in the meeting with Zan, but it is really your call.
300409 -        ref DIT 1 GY8F
300410 -
300411 -           [On 060724 notified Kaiser of new information on family
300412 -           history of blood clot problems, and report of medical study
300413 -           showing genetic cause. ref SDS 5 NL5Q
300415 -         ..
300416 -    6.  See you next month, and have a good vacation. ref DIT 1 OY8O
300417 -
300418 -
300419 -
300420 -
300421 -
300422 -
300423 -
300424 -
300425 -
300426 -
300427 -
3005 -